Soluble Markers in Rheumatoid Arthritis
Author Information
Author(s): T. Kogure, T. Itoh, Y. Shimada, T. Shintani, H. Ochiai, K. Terasawa
Primary Institution: Toyama Medical and Pharmaceutical University
Hypothesis
What is the correlation among soluble CD4, CD8, and CD23 in patients with rheumatoid arthritis?
Conclusion
The study found that sCD23 levels are significantly elevated in rheumatoid arthritis patients compared to healthy controls, indicating its potential as a marker for immune status.
Supporting Evidence
- The serum level of sCD4 showed no significant difference between RA patients and healthy controls.
- Both sCD8 and sCD23 levels were higher in RA patients compared to healthy controls.
- A significant correlation was found between sCD23 and IgM-RF.
Takeaway
This study looked at certain markers in the blood of people with rheumatoid arthritis and found that one marker, sCD23, is much higher in these patients, which might help doctors understand their immune system better.
Methodology
Serum levels of sCD4, sCD8, and sCD23 were measured using ELISA in 25 RA patients and compared with 20 healthy controls.
Limitations
The study had a small sample size and focused only on specific soluble markers.
Participant Demographics
25 patients (19 females and 6 males) with a mean age of 58.3 years.
Statistical Information
P-Value
0.0049
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website